Avoid Mishaps With SGLT2 Inhibitors

More inpatients will get SGLT2 inhibitors...canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin.

These meds were originally approved for type 2 diabetes. But now they’re also recommended for certain patients with heart failure.

Avoid mishaps with SGLT2 inhibitors as use increases.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote